According to IMARC Group latest report titled “Neurostimulation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on neurostimulation devices market share. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global neurostimulation devices market reached a value of US$ 7.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.4 Billion by 2027, exhibiting a CAGR of 12.3% during 2022-2027.
Neurostimulation device refers to a programmable medical equipment that is designed to deliver electrical stimulation to a specific part of the human brain. Such devices are used in the treatment of numerous neurological conditions, such as immobility disorder, epilepsy, and Parkinson’s diseases. Neurostimulation devices are also used to stimulate, inhibit, modify, regulate, and alter the activities of the autonomous, central, and peripheral nervous system in the patients’ body.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/neurostimulation-devices-market/requestsample
The high prevalence of chronic neurological disorders due to stress, anxiety, and depression, particularly among the millennial population, is one of the major factors augmenting the market growth. Furthermore, the increasing geriatric population who are more prone to neurological ailments is also driving the demand for neurostimulation devices. Moreover, the rising number of minimally invasive surgeries, along with increasing investments in the advancements of healthcare facilities, further propels the market growth. Extensive research and development (R&D) activities pertaining to the use of neurostimulation devices in treating asthma, obsessive-compulsive disorder, and interstitial cystitis, are expected to further bolster the market growth.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/neurostimulation-devices-market
Competitive Landscape with Key players:
The competitive landscape of the industry has also been examined with some of the key players.
- Biocontrol Medical
- Boston Scientific Corporation
- Cyberonics Inc.
- Medtronic Inc.
- Neuronetics Inc.
- Nevro Corporation
- Jude Medical Inc.
Global Neurostimulation Devices Market Segmentation:
Our report has categorized the market based on region, stimulation type, device type, application and end-use.
By Stimulation Type:
- Internal Neurostimulation
- External Neurostimulation
By Device Type:
- SCS (Spinal Cord Stimulation) Devices
- DBS (Deep Brain Stimulation) Devices
- SNS (Sacral Nerve Stimulation) Devices
- VNS (Vagus Nerve Stimulation) Devices
- GES (Gastric Electrical Stimulation) Devices
- Transcutaneous Electrical Nerve Stimulation Devices
- Transcranial Magnetic Stimulation Devices
- Pain Management
- Essential Tremors
- Urinary and Fecal Incontinence
- Parkinson’s Disease
- Rehabilitation Centers
- Medical Clinics
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800